Toxotis Investments Public Limited is a public company listed in the parallel market of the Cyprus Stock Exchange. Its shares are traded under the code COV.
Toxotis Investments Public Ltd. is engaged in the investments business. It can do investments in shares to companies listed CSE and in shares not listed in the CSE. Due to the fact that the company is not listed as an investment company of close type is flexible to execute profitable Investments outside the stock exchange as well.
The company was formerly known as Covotsos Enterprises Limited and changed its name to Toxotis Investments Public Ltd. in November 1999.
The company was founded in 1989 and is based in Nicosia, Cyprus.
1989
Served areaEurope
HeadquartersThemistokli Dervi 40, 3rd floor, Office 301, 1066 Nicosia – Cyprus
Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 |
---|---|---|---|
Assets | N/A | 3,769,469.00 | 3,844,591.00 |
Noncurrent Assets | N/A | 2,415,660.00 | 2,500,479.00 |
Investment Property | N/A | 1,030,000.00 | 1,030,000.00 |
Noncurrent Loans And Receivables | N/A | 1,385,660.00 | 1,470,479.00 |
Current Assets | N/A | 1,353,809.00 | 1,344,112.00 |
Trade And Other Current Receivables | N/A | 478,669.00 | 478,669.00 |
Current Loans And Receivables | N/A | 57,491.00 | 58,992.00 |
Cash and cash equivalents | 6,000.00 | 18,148.00 | 4,072.00 |
Equity And Liabilities | N/A | 3,769,469.00 | 3,844,591.00 |
Equity | 597,757.00 | 189,063.00 | 37,920.00 |
Issued Capital | N/A | 621,000.00 | 621,000.00 |
Retained Earnings | N/A | -518,298.00 | -669,441.00 |
Other Reserves | N/A | 86,361.00 | 86,361.00 |
Liabilities | N/A | 3,580,406.00 | 3,806,671.00 |
Noncurrent Liabilities | N/A | 149,570.00 | 149,570.00 |
Deferred Tax Liabilities | N/A | 149,570.00 | 149,570.00 |
Current Liabilities | N/A | 3,430,836.00 | 3,657,101.00 |
Trade And Other Current Payables | N/A | 361,335.00 | 423,561.00 |
Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
---|---|---|
Revenue From Interest | 68,921.00 | 67,663.00 |
Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 202,656.00 | -18,630.00 |
Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 202,656.00 | -18,630.00 |
Profit Loss From Operating Activities | -323,225.00 | -31,895.00 |
Finance Costs | 106,666.00 | 119,248.00 |
Profit Loss Before Tax | -429,891.00 | -151,143.00 |
Income Tax Expense Continuing Operations | -21,197.00 | 0.00 |
Profit (loss) | -408,694.00 | -151,143.00 |
Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 |
---|---|---|---|
Profit (loss) | N/A | -408,694.00 | -151,143.00 |
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | N/A | 202,656.00 | -18,630.00 |
Adjustments For Fair Value Gains Losses | N/A | -17,811.00 | -2,878.00 |
Cash Flows From Used In Operating Activities | N/A | -249,362.00 | -59,130.00 |
Cash Advances And Loans Made To Other Parties Classified As Investing Activities | N/A | 173,921.00 | 0.00 |
Cash Flows From Used In Investing Activities | N/A | -173,921.00 | 0.00 |
Proceeds From Borrowings Classified As Financing Activities | N/A | 500,000.00 | 164,066.00 |
Repayments Of Borrowings Classified As Financing Activities | N/A | 34,600.00 | 0.00 |
Interest Paid Classified As Financing Activities | N/A | 29,969.00 | 119,012.00 |
Cash Flows From Used In Financing Activities | N/A | 435,431.00 | 45,054.00 |
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | 12,148.00 | -14,076.00 |
Cash and cash equivalents | 6,000.00 | 18,148.00 | 4,072.00 |
Please note that some sums might not add up.
CY0001500715
LEI213800P79CY54Q648G91
SectorCSE General Index
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.